Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Involvement of nonclassical MHC class Ib molecules in heat shock protein-mediated anti-tumor responses.

Goyos A, Guselnikov S, Chida AS, Sniderhan LF, Maggirwar SB, Nedelkovska H, Robert J.

Eur J Immunol. 2007 Jun;37(6):1494-501.

2.
3.

Novel nonclassical MHC class Ib genes associated with CD8 T cell development and thymic tumors.

Goyos A, Ohta Y, Guselnikov S, Robert J.

Mol Immunol. 2009 May;46(8-9):1775-86. doi: 10.1016/j.molimm.2009.01.016. Epub 2009 Feb 23.

4.

Anti-tumor MHC class Ia-unrestricted CD8 T cell cytotoxicity elicited by the heat shock protein gp96.

Goyos A, Cohen N, Gantress J, Robert J.

Eur J Immunol. 2004 Sep;34(9):2449-58.

5.

A critical role of non-classical MHC in tumor immune evasion in the amphibian Xenopus model.

Haynes-Gilmore N, Banach M, Edholm ES, Lord E, Robert J.

Carcinogenesis. 2014 Aug;35(8):1807-13. doi: 10.1093/carcin/bgu100. Epub 2014 Apr 28.

6.

Xenopus, a unique comparative model to explore the role of certain heat shock proteins and non-classical MHC class Ib gene products in immune surveillance.

Robert J, Goyos A, Nedelkovska H.

Immunol Res. 2009 Dec;45(2-3):114-22. doi: 10.1007/s12026-009-8094-9. Epub 2009 Feb 3.

7.

The analysis of the natural killer-like activity of human cytolytic T lymphocytes revealed HLA-E as a novel target for TCR alpha/beta-mediated recognition.

Pietra G, Romagnani C, Falco M, Vitale M, Castriconi R, Pende D, Millo E, Anfossi S, Biassoni R, Moretta L, Mingari MC.

Eur J Immunol. 2001 Dec;31(12):3687-93.

8.

Analysis of HLA-E expression in human tumors.

Marín R, Ruiz-Cabello F, Pedrinaci S, Méndez R, Jiménez P, Geraghty DE, Garrido F.

Immunogenetics. 2003 Feb;54(11):767-75. Epub 2003 Jan 30.

PMID:
12618909
9.
10.
11.

The non-classical MHC class I molecule Qa-1(b) inhibits classical MHC class I-restricted cytotoxicity of cytotoxic T lymphocytes.

Lohwasser S, Kubota A, Salcedo M, Lian RH, Takei F.

Int Immunol. 2001 Mar;13(3):321-7.

PMID:
11222501
12.

Molecular and cellular requirements for enhanced antigen cross-presentation to CD8 cytotoxic T lymphocytes.

Oizumi S, Strbo N, Pahwa S, Deyev V, Podack ER.

J Immunol. 2007 Aug 15;179(4):2310-7.

13.
14.

The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape.

Algarra I, García-Lora A, Cabrera T, Ruiz-Cabello F, Garrido F.

Cancer Immunol Immunother. 2004 Oct;53(10):904-10. Epub 2004 Apr 7. Review.

PMID:
15069585
15.
16.
17.

Complex interplay of activating and inhibitory signals received by Vgamma9Vdelta2 T cells revealed by target cell beta2-microglobulin knockdown.

Trichet V, Benezech C, Dousset C, Gesnel MC, Bonneville M, Breathnach R.

J Immunol. 2006 Nov 1;177(9):6129-36.

18.
19.

Minor histocompatibility antigen-specific MHC-restricted CD8 T cell responses elicited by heat shock proteins.

Robert J, Gantress J, Rau L, Bell A, Cohen N.

J Immunol. 2002 Feb 15;168(4):1697-703.

20.

Tumor defense by murine cytotoxic T cells specific for peptide bound to nonclassical MHC class I.

Griffiths E, Ong H, Soloski MJ, Bachmann MF, Ohashi PS, Speiser DE.

Cancer Res. 1998 Oct 15;58(20):4682-7.

Supplemental Content

Support Center